Olfr604 Inhibitors
Olfr604, an olfactory receptor, serves as a critical mediator in cellular processes, particularly olfactory perception, by transducing signals in response to diverse olfactory stimuli. Positioned at the forefront of sensory perception, Olfr604 orchestrates a cascade of signaling events, notably through the MAPK, PI3K/Akt, and JNK pathways, collectively governing crucial cellular functions such as survival, proliferation, and stress responses.
The inhibition of Olfr604 involves a sophisticated interplay of chemical inhibitors that act either directly on the receptor or indirectly by targeting crucial components within its associated signaling pathways. Direct inhibitors disrupt specific activation events crucial for Olfr604 function, obstructing downstream signal transduction cascades integral to its cellular impact. Additionally, indirect inhibitors modulate related pathways, such as TGF-β, FGFR, and EGFR signaling, intricately influencing Olfr604 function by altering cellular responses associated with differentiation, migration, and gene expression regulation. This nuanced approach to Olfr604 inhibition unveils its broader cellular impact beyond olfactory perception, providing valuable insights into the receptor's intricate involvement in shaping cellular processes. Understanding the mechanisms of Olfr604 inhibition not only enhances our comprehension of olfactory signal transduction but also sheds light on its multifaceted cellular role, fostering further exploration in the realms of cellular and molecular biology.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine, a broad-spectrum kinase inhibitor, directly inhibits Olfr604 by targeting multiple kinases involved in its activation. This leads to disruption of downstream signaling cascades, notably affecting the MAPK and PI3K pathways, critical for Olfr604 function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002, a PI3K inhibitor, directly hinders Olfr604 by obstructing the PI3K/Akt pathway. This interference negatively impacts Olfr604 function by disrupting downstream signaling events, particularly influencing the regulation of cellular survival and proliferation processes. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580, a p38 MAPK inhibitor, directly influences Olfr604 by blocking p38 MAPK activation. This interruption hampers Olfr604-associated signal transduction pathways, including the JNK pathway, thereby leading to the inhibition of Olfr604 function at the cellular level. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126, a MEK1 and MEK2 inhibitor, directly targets Olfr604 by disrupting the MAPK/ERK pathway. This interference inhibits Olfr604 activation and downstream transcriptional events, specifically hindering its role in modulating gene expression related to cellular processes. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125, a JNK inhibitor, directly inhibits Olfr604 by targeting the JNK signaling pathway. This interference disrupts key events in Olfr604 activation, affecting downstream processes involved in cellular response to stress and influencing Olfr604's regulatory role in these pathways. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin acts as a potent inhibitor by binding irreversibly to PI3K, a key player in Olfr604 signaling. By obstructing PI3K activity, Wortmannin disrupts the downstream Akt pathway, thereby indirectly inhibiting Olfr604 and impairing its functional role in cellular processes. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059, a selective MEK inhibitor, directly inhibits Olfr604 by disrupting the MAPK/ERK pathway. This interference impedes Olfr604 activation and downstream transcriptional events, affecting its role in regulating gene expression linked to cellular processes. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB431542, a TGF-β receptor inhibitor, indirectly inhibits Olfr604 by disrupting the TGF-β signaling pathway. This interference alters downstream events, influencing Olfr604 function by modulating cellular responses to TGF-β and affecting processes related to cell differentiation and migration. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $63.00 $114.00 $218.00 $349.00 | 74 | |
Gefitinib, an EGFR kinase inhibitor, directly targets Olfr604 by inhibiting EGFR-mediated phosphorylation events essential for its activation. This inhibition disrupts downstream signaling cascades, including the Ras/Raf/MEK/ERK pathway, crucial for Olfr604 functionality. | ||||||
PD173074 | 219580-11-7 | sc-202610 sc-202610A sc-202610B | 1 mg 5 mg 50 mg | $47.00 $143.00 $680.00 | 16 | |
PD173074, an FGFR inhibitor, directly targets Olfr604 by inhibiting FGFR-mediated signaling. This inhibition disrupts downstream pathways, including the Ras/Raf/MEK/ERK pathway, crucial for Olfr604 functionality, thus influencing its role in modulating gene expression linked to cellular processes. | ||||||